ÀÛ¼ºÀÏ : 25-11-18 12:26
|
....
|
|
|
±Û¾´ÀÌ :
111
 Á¶È¸ : 3
|
ÓßúÉÒýÑûàõì»å룬ð¯ìéóÜ×éÄ KAMAGRA-100 â©ÍýÚ«Ï¢ùßø¸ èÙèÙ既Ñ¢ÓâéÑÑÌíå¡£îÏγìÔÓøð²ðãîÜ íàåÕå·£¨Sildenafil 100mg£© ì¤Ðì Ï¢ùß即ûù¡¢öááÜýå⥡¢Òýðúâ©ÍýÏ¢Ú« ûú øµåÚ攜Óá îÜ÷åàõ£¬î¤ãæâ¢ÑûàõñéÞªßÈáôü¶çÊ¡£ïáü¬îÜÞÅéÄÛ°ÛöÜôÐÁç¯úÂå·üù£¬ü½Î¼ÌõÓðäÌîïæ¨ÜùíÂéÄÍó𤡣ÜâÙþíâÌ¿ùê îöÊ«Ëïì¡¡¢×üßÉâ¦Ëàì¤ÐàÞÅéÄíºüÞÏú£¬ð«Íêð¯ìéóÞÅéÄ KAMAGRA-100 îÜèÇïÚãæâ¢教ùÊ¡£
3330.jpg
ìé¡¢Öõú° KAMAGRA-100 Ï¢ùßø¸îÜå·×â÷åàõ
KAMAGRA-100 â©ÍýÚ«Ï¢ùßø¸ ãÀìéðú PDE5 åäð¤ð¥£¬üÀàõà÷ÝÂ為 à¤ò¢ÑáÞª£¨Sildenafil£©¡£Ðìñ«é©íÂéÄѦð¤åýù»£º
åäð¤ PDE5 酶üÀàõ
PDE5 ãÀëäÌìúØúô÷Ò®ÝÂú° cGMP îÜμËõ酶¡£
à¤ò¢Ñáުʦåäð¤ PDE5£¬ÞÅ cGMP â©øÁã®ÍÔ£¬õµòäøÁüÁÑ¿à¢í壬ñòÊ¥úì×µ£¬Ó¹ÓðÚúÑÃüùÍý¡£
Ï¢ùßýåâ¥öá
å·Úª÷âΦϢ˷黏دòÁïÈòäìýúìäû£¬ùØóÝ»ÝÂâÏÔ¤ÓÛÞó£¨First-pass metabolism£©£¬Ýïîî÷ÖÏ¢Ü×ïüÑÃüùÌÚöá¡£
×üßÉãËúÐúéãÆÏ¢ùßø¸ÑÃüùøÁгãÁÊà å³ 15–30 ÝÂñ¤£¨ÕÎê¹£ºInternational Journal of Impotence Research, 2018£©¡£
å·üùò¥áÙãÁÊà
KAMAGRA-100 îÜå·üùʦò¥áÙ 4–6 á³ãÁ£¬Ý»ÝÂÞÅéÄíºÊ¦Ó¹ 8 á³ãÁ£¬æ¨àõí©ÌÔÒãÁíÂéÄ¡£
îÏÞÁå·×âò±ãÛÓß ð¯ìéóÞÅéÄ KAMAGRA-100 îÜãæâ¢ ÞªßÈñìé©£¬Ê¦幫ð¾×âú°為ä§麼 ÍöÜÙÜ×éÄÑÃüùÌÚöᣬì¤Ðà為ù¼àõí©Ìù±âÎðíî¤î¦ÒöÓ¹ÓðÚúÑÃüùÍý¡£
죡¢âÏóÞÅéÄ KAMAGRA-100 îñîÜñÞÝá
ð¯ìéóÞÅéÄ KAMAGRA-100 îñ£¬Ëïì¡ñ¼ëòì¤ù»ÞÀú££º
í¿âóì¢ÞÔ
ü¬ìãí»ãóÙÒêó åññìãýúìηòðÜ»¡¢î¸úìäâûäÍÔúìä⣬ûäïáî¤Ü×éÄ õ¦ß«ç¤×¾å·Úª¡£
研ϼúéãÆ£¬ãýúìηü´íºî¤Ú±í¿âóì¢ÞÔîÜï×üÏù»ÞÅéÄ PDE5 åäð¤ð¥£¬Ê¦ÒöñòÊ¥ãýÑ¿ÌÀúìù¦úÏ£¨ÕÎê¹£ºAmerican Heart Association, 2020£©¡£
àÔ÷ÉÍöÜÙûäÌîãÝßÒ÷¾
ÍÔò·óÉüåæÅòÀå·Úªýå⥠60–120 ÝÂñ¤£¬Ë½î¸úìå·ÒØÓø 20–30%£¨ÕÎê¹£ºJournal of Sexual Medicine, 2016£©¡£
ÍöÜÙÜ×éÄÒöð«ÍÔúìñéà¤ò¢ÑáÞªÒØÓø£¬ð«ã®ÚúÑÃÌãÓøûúò¥áÙãÁÊà¡£
ñÞÝáá´Õáâ©
âÌæÔÏ¢ùßø¸Ê¦òÁïÈýå⥣¬Ó£Ï¢ËëãÁá´Õáâ©êóð¾åÚå·ø¸éÁú°¡£
ÜÁò¥à¢îê¡¢Û¯鬆îÜü»ÌÑ
ãý×âßÒ÷¾æ¨àõí©Ìüåç¯úÂå·üù£¬Û¯鬆ãýï×ʦð«ÍÔ KAMAGRA-100 îÜêóüùàõ¡£
3333.png
ß²¡¢âÏóÜ×éÄ KAMAGRA-100 îÜÜÆö®
ÑÃã·ð¥Õá
Ëïì¡ãæâ¢ðô 50mg ËÒã·£¨65 á¨ì¤ß¾Ñûàõʦðô 25mg ËÒã·£©¡£
å´üùÍýÜôð룬ʦðàïÚò¸ 100mg£¬Ó£ØßìíÜôʦõ±Î¦ 100mg¡£
Ü×éÄÛ°Ûö
íâÏ¢ùßø¸Û¯ìýÏ¢ñéí»æÔéÁú°£¬ùØóîºíÄûäòÁïÈ吞ù»¡£
ÑÃüùøÁг 15–30 ÝÂñ¤£¬å·üùʦò¥áÙ 4–6 á³ãÁ£¬Ý»ÝÂÞÅéÄíºÊ¦Ó¹ 8 á³ãÁ¡£
àõí©Ìù±âÎðíî¤
PDE5 åäð¤ð¥ÐÁî¤àõí©Ìù»Û¡ýÆíÂéÄ£¬Ó¤âíÜ×éÄÙíÛöí»ÔÑÚúÑá£
κóÌÜùíÂéÄ
ßÈ̸ÌîÚ°ÜùíÂéÄøÐÎÀ£ºÔéý»¡¢臉ûõ¡¢Þ¬ßÝ¡¢ÌîÚ°Ôé÷Ô¡£
å´õóúÞýØÚ¿¡¢Ð¼ÖÔé÷ÔûäãÊÕôì¶ßÈ£¬ëëØ¡即ïÎå·並ö¦ì¢¡£
Ú¸ÏÐ FDA Ëïì¡£¬õóúÞåññìÜùíÂéÄãÁ£¬ëëØ¡即ÚüöèÐáÏï³ü¥ûäîñèÙÐáòࣨÕÎê¹£ºFDA Drug Safety Communication, 2019£©¡£
33.png
ÞÌ¡¢ÍöÜÙæ¨ÚùýÜ×éÄ KAMAGRA-100 îÜó¬ì¶
ÍöÜÙÜ×éÄ
ÑÃüùõÌöᣬúìñéà¤ò¢ÑáÞªÒØÓøÓ¹ÜèãÁÊàõÌÓ¡£
×üßÉâ¦ËàúéãÆ£¬ÍöÜÙÜ×éÄʦÞÅøÁгÑÃüùãÁÊàõêÓå³ 20 ÝÂñ¤£¨ÕÎê¹£ºInternational Journal of Clinical Pharmacology, 2017£©¡£
ÌîãÝýÜ×éÄ
êÖÚÂÊïíºÊ¦àÔ÷É£¬Ó£ÑÃüùõªØ·£¬úìñéÒØÓøÕÔ£
ÍÔò·óÉýÜ×éÄ
ÑÃüùæÅòÀ 60–120 ÝÂñ¤£¬å·üù˽£
îöÊ«Ëïì¡ãæâ¢õÌû¿àÔ÷É ÍöÜÙûäÌîãÝý 1–2 á³ãÁ Ü×éÄ£¬ì¤üòÔðõÌÊ¢ KAMAGRA-100 ÑÃüùüùÍý¡£
23232323.png
çé¡¢KAMAGRA-100äÌîïÞÅéÄæ¨ñ¼ëòÞÀú£
ùØóæ¨õ¦ß«ç¤×¾å·ÚªÔÒãÁÞÅéÄ
ʦÒöÓôöÈúìäâÐá˽£¬ñòÊ¥ãýúìηù¦úÏ¡£
ùØóÍÔò·óÉæ¨Î¦ÕáñÐïñ
ʦ˽î¸úìñéÒØÓø£¬ç¯úÂÚúÑÃÌãÓø¡£
ñåáúð¥ÕáЮÛô
ØßìíÜôʦõ±Î¦ 100mg£¬ùØóñòÊ¥ÜùíÂéÄù¦úÏ¡£
׺ëòËÁìÑô÷òõÚãëë
å´õóúÞÔéý»¡¢ãÊÕôì¶ßÈ¡¢ýØÚ¿ÔõñøßÒ£¬Ø¡即ïÎå·並ö¦ì¢¡£
׿¡¢Ì¿Ö壺ãæâ¢ÞÅéÄ KAMAGRA-100 îÜüÜÑÑóþÕÔ
ð¯ìéóÞÅéÄ KAMAGRA-100 â©ÍýÚ«Ï¢ùßø¸ îÜÑûàõ£¬Ê¦ñåâàì¤ù»óþÕÔ£º
à»í¿âóì¢ÞÔü¬ìãäÌîï¡£
àÔ÷É ÍöÜÙûäÌîãÝý 1–2 á³ãÁ Ü×éÄ¡£
ÑÃã·ð¥Õá 50mg£¬ù±é©ãÁðàïÚò¸ 100mg¡£
Ï¢ùßø¸Û¯ìýÏ¢ñéí»æÔéÁú°£¬ÔõÓâ 15–30 ÝÂñ¤ ÑÃüù¡£
àõí©Ìù±âÎðí¬並κóÌÜùíÂéÄ¡£
íæäÄì¤ß¾Û°Ûö£¬ãæâ¢å¥Òö äÌîï¡¢êóüùò¢ÞÅéÄ KAMAGRA-100£¬ð«ã®ÚúÑÃÌãÓøæ¨ò¥ÎùÓø£¬ñìã¦àõßæüÀãáãý¡£
ßÓμ產ù¡õÏôÀ£ºìÔÓøâíòäÏ¢ïáù¡ù±××ÌÍPriligy(POXET-60) ClimaxìÔÓøãêêú Ú¸ÏÐüÜÑÑêÉʨViagra ìÔÓøäªüùäÅêÎíࣨLevifil£© Ú¸ÏС¼MMC¡½MAXMAN äû÷¾ÍýÔÐêÎì»Ë¼MALEGRA ýÙâ©Ð¡ Extra Super Filanað¯ÞÌÓÛAvanafilõ±ÐäêÎì»Ë¼äªüù ÌÚÒý產ù¡ßÙï×òäìýˬäÅå·ÏÑwww.kl19.tw 24á³ãÁËÔÜ×line:kl198888
æÅãßæóÔÁ£ºKAMAGRA-100 ïáü¬ÞÅéÄÛ°Ûöæ¨ð¥Õáò¦Ñõ
|
|